Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Cash on Hand 2010-2024 | AMGN

Amgen cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Amgen cash on hand for the quarter ending September 30, 2024 was $9.011B, a 74.06% decline year-over-year.
  • Amgen cash on hand for 2023 was $10.944B, a 17.61% increase from 2022.
  • Amgen cash on hand for 2022 was $9.305B, a 15.78% increase from 2021.
  • Amgen cash on hand for 2021 was $8.037B, a 24.51% decline from 2020.
  
Amgen Annual Cash on Hand
(Millions of US $)
2023 $10,944
2022 $9,305
2021 $8,037
2020 $10,647
2019 $8,911
2018 $29,304
2017 $41,678
2016 $38,085
2015 $31,382
2014 $27,026
2013 $19,401
2012 $24,061
2011 $20,641
2010 $17,422
2009 $13,442
Amgen Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $9,011
2024-06-30 $9,301
2024-03-31 $9,708
2023-12-31 $10,944
2023-09-30 $34,741
2023-06-30 $34,248
2023-03-31 $31,561
2022-12-31 $9,305
2022-09-30 $11,478
2022-06-30 $7,183
2022-03-31 $6,544
2021-12-31 $8,037
2021-09-30 $12,921
2021-06-30 $8,082
2021-03-31 $10,566
2020-12-31 $10,647
2020-09-30 $12,360
2020-06-30 $11,421
2020-03-31 $8,012
2019-12-31 $8,911
2019-09-30 $20,853
2019-06-30 $21,758
2019-03-31 $26,301
2018-12-31 $29,304
2018-09-30 $29,921
2018-06-30 $29,395
2018-03-31 $32,172
2017-12-31 $41,678
2017-09-30 $41,351
2017-06-30 $39,227
2017-03-31 $38,398
2016-12-31 $38,085
2016-09-30 $37,980
2016-06-30 $35,034
2016-03-31 $34,740
2015-12-31 $31,382
2015-09-30 $31,120
2015-06-30 $29,993
2015-03-31 $27,118
2014-12-31 $27,026
2014-09-30 $28,075
2014-06-30 $26,188
2014-03-31 $19,802
2013-12-31 $19,401
2013-09-30 $22,558
2013-06-30 $22,018
2013-03-31 $21,271
2012-12-31 $24,061
2012-09-30 $25,374
2012-06-30 $22,475
2012-03-31 $19,374
2011-12-31 $20,641
2011-09-30 $17,676
2011-06-30 $19,172
2011-03-31 $15,358
2010-12-31 $17,422
2010-09-30 $17,049
2010-06-30 $14,523
2010-03-31 $14,117
2009-12-31 $13,442
2009-09-30 $14,013
2009-06-30 $11,965
2009-03-31 $10,378
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $155.831B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $118.101B 49.77
Vertex Pharmaceuticals (VRTX) United States $115.983B 0.00
Gilead Sciences (GILD) United States $111.865B 20.26
CSL (CSLLY) Australia $86.479B 0.00
Regeneron Pharmaceuticals (REGN) United States $81.813B 18.62
GSK (GSK) United Kingdom $69.845B 8.08
Argenex SE (ARGX) Netherlands $35.683B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.832B 0.00
BioNTech SE (BNTX) Germany $25.947B 0.00
Biogen (BIIB) United States $23.025B 9.89
Illumina (ILMN) United States $21.727B 79.18
BeiGene (BGNE) Cayman Islands $18.949B 0.00
Moderna (MRNA) United States $14.719B 0.00
Incyte (INCY) United States $13.561B 0.00
Genmab (GMAB) Denmark $13.546B 19.87
Insmed (INSM) United States $13.205B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.092B 28.08
Bio-Techne Corp (TECH) United States $11.289B 43.59
Vaxcyte (PCVX) United States $11.017B 0.00
Sarepta Therapeutics (SRPT) United States $10.555B 95.26
Exelixis (EXEL) United States $9.947B 22.62
Exact Sciences (EXAS) United States $9.822B 0.00
QIAGEN (QGEN) Netherlands $9.660B 19.87
Revolution Medicines (RVMD) United States $9.552B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Intra-Cellular Therapies (ITCI) United States $9.059B 0.00
Roivant Sciences (ROIV) United Kingdom $8.741B 0.00
Repligen (RGEN) United States $7.942B 103.47
Ascendis Pharma (ASND) Denmark $7.437B 0.00
Legend Biotech (LEGN) United States $7.247B 0.00
Nuvalent (NUVL) United States $6.589B 0.00
Blueprint Medicines (BPMC) United States $6.138B 0.00
Halozyme Therapeutics (HALO) United States $5.814B 13.13
Viking Therapeutics (VKTX) United States $5.753B 0.00
Cytokinetics (CYTK) United States $5.626B 0.00
Krystal Biotech (KRYS) United States $5.243B 86.81
Avidity Biosciences (RNA) United States $5.078B 0.00
ADMA Biologics Inc (ADMA) United States $5.035B 53.25
Axsome Therapeutics (AXSM) United States $4.759B 0.00
Arcellx (ACLX) United States $4.716B 0.00
Biohaven (BHVN) United States $4.570B 0.00
Alkermes (ALKS) Ireland $4.482B 15.05
Ultragenyx Pharmaceutical (RARE) United States $4.250B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.951B 0.00
Immunovant (IMVT) United States $3.896B 0.00
Guardant Health (GH) United States $3.828B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.628B 0.00
ImmunityBio (IBRX) United States $3.509B 0.00
Denali Therapeutics (DNLI) United States $3.486B 0.00
Apellis Pharmaceuticals (APLS) United States $3.452B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.314B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.082B 0.00
Merus (MRUS) Netherlands $3.037B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.034B 0.00
Edgewise Therapeutics (EWTX) United States $3.028B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.027B 0.00
Vera Therapeutics (VERA) United States $2.978B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $2.855B 0.00
Amicus Therapeutics (FOLD) United States $2.839B 0.00
Kymera Therapeutics (KYMR) United States $2.818B 0.00
Vericel (VCEL) United States $2.799B 945.17
SpringWorks Therapeutics (SWTX) United States $2.700B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.692B 20.74
Zai Lab (ZLAB) China $2.560B 0.00
Belite Bio (BLTE) United States $2.524B 0.00
Iovance Biotherapeutics (IOVA) United States $2.511B 0.00
Scholar Rock Holding (SRRK) United States $2.497B 0.00
Protagonist Therapeutics (PTGX) United States $2.482B 15.66
Twist Bioscience (TWST) United States $2.473B 0.00
Janux Therapeutics (JANX) United States $2.440B 0.00
Geron (GERN) United States $2.430B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.334B 0.00
IDEAYA Biosciences (IDYA) United States $2.299B 0.00
Ligand Pharmaceuticals (LGND) United States $2.202B 54.98
WAVE Life Sciences (WVE) Singapore $2.189B 0.00
CG Oncology (CGON) United States $2.187B 0.00
Keros Therapeutics (KROS) United States $2.181B 0.00
Akero Therapeutics (AKRO) United States $2.178B 0.00
Bavarian Nordic (BVNRY) Denmark $2.117B 12.97
Mirum Pharmaceuticals (MIRM) United States $2.087B 0.00
NeoGenomics (NEO) United States $1.975B 0.00
Beam Therapeutics (BEAM) United States $1.953B 0.00
Apogee Therapeutics (APGE) United States $1.930B 0.00
MannKind (MNKD) United States $1.903B 49.29
Harmony Biosciences Holdings (HRMY) United States $1.895B 15.75
Disc Medicine (IRON) United States $1.890B 0.00
NovoCure (NVCR) Jersey $1.849B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.774B 0.00
Fortrea Holdings (FTRE) United States $1.749B 55.71
Celldex Therapeutics (CLDX) United States $1.740B 0.00
Arvinas (ARVN) United States $1.725B 0.00
Structure Therapeutics (GPCR) United States $1.724B 0.00
Galapagos (GLPG) Belgium $1.662B 0.00
Dynavax Technologies (DVAX) United States $1.625B 95.08
Immunocore Holdings (IMCR) United Kingdom $1.607B 0.00
Nurix Therapeutics (NRIX) United States $1.585B 0.00
Certara (CERT) United States $1.573B 44.41
Neumora Therapeutics (NMRA) United States $1.566B 0.00
Viridian Therapeutics (VRDN) United States $1.554B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.523B 0.00
Travere Therapeutics (TVTX) United States $1.425B 0.00
Intellia Therapeutics (NTLA) United States $1.406B 0.00
Spyre Therapeutics (SYRE) United States $1.389B 0.00
Myriad Genetics (MYGN) United States $1.376B 0.00
Praxis Precision Medicines (PRAX) United States $1.362B 0.00
MiMedx (MDXG) United States $1.355B 35.46
Day One Biopharmaceuticals (DAWN) United States $1.345B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.332B 0.00
Arcus Biosciences (RCUS) United States $1.307B 0.00
Novavax (NVAX) United States $1.288B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.199B 0.00
ANI Pharmaceuticals (ANIP) United States $1.175B 16.01
Rocket Pharmaceuticals (RCKT) United States $1.166B 0.00
Mesoblast (MESO) Australia $1.162B 0.00
Gyre Therapeutics (GYRE) United States $1.099B 0.00
Applied Therapeutics (APLT) United States $1.079B 0.00
Cogent Biosciences (COGT) United States $0.992B 0.00
Septerna (SEPN) $0.968B 0.00
Bicara Therapeutics (BCAX) United States $0.967B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.963B 0.00
Vir Biotechnology (VIR) United States $0.957B 0.00
Upstream Bio (UPB) United States $0.954B 0.00
LENZ Therapeutics (LENZ) United States $0.944B 0.00
Zymeworks (ZYME) United States $0.942B 0.00
Nuvation Bio (NUVB) United States $0.909B 0.00
Immatics (IMTX) Germany $0.905B 0.00
ArriVent BioPharma (AVBP) United States $0.896B 0.00
89BIO (ETNB) United States $0.889B 0.00
Liquidia Technologies (LQDA) United States $0.859B 0.00
Cytek Biosciences (CTKB) United States $0.832B 0.00
Rapport Therapeutics (RAPP) United States $0.824B 0.00
Castle Biosciences (CSTL) United States $0.809B 144.40
AbCellera Biologics (ABCL) Canada $0.803B 0.00
Pacira BioSciences (PCRX) United States $0.802B 7.56
Kura Oncology (KURA) United States $0.782B 0.00
Pliant Therapeutics (PLRX) United States $0.782B 0.00
Avid Bioservices (CDMO) United States $0.781B 0.00
Tyra Biosciences (TYRA) United States $0.777B 0.00
Prothena (PRTA) Ireland $0.777B 0.00
Anavex Life Sciences (AVXL) United States $0.765B 0.00
Replimune (REPL) United States $0.756B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.756B 0.00
Erasca (ERAS) United States $0.735B 0.00
CARGO Therapeutics (CRGX) United States $0.724B 0.00
Cullinan Therapeutics (CGEM) United States $0.712B 0.00
Entrada Therapeutics (TRDA) United States $0.675B 11.35
Tectonic Therapeutic (TECX) United States $0.662B 0.00
BioAge Labs (BIOA) United States $0.661B 0.00
Arbutus Biopharma (ABUS) United States $0.656B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.646B 0.00
Adaptive Biotechnologies (ADPT) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
AnaptysBio (ANAB) United States $0.644B 0.00
Oric Pharmaceuticals (ORIC) United States $0.644B 0.00
CorMedix Inc (CRMD) United States $0.627B 0.00
Dianthus Therapeutics (DNTH) United States $0.600B 0.00
Oculis Holding AG (OCS) Switzerland $0.597B 0.00
Stoke Therapeutics (STOK) United States $0.597B 0.00
Mineralys Therapeutics (MLYS) United States $0.591B 0.00
Immunome (IMNM) United States $0.588B 0.00
ChromaDex (CDXC) United States $0.583B 763.00
Corvus Pharmaceuticals (CRVS) United States $0.574B 0.00
CureVac (CVAC) Germany $0.573B 4.65
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.570B 0.00
MBX Biosciences (MBX) United States $0.552B 0.00
Humacyte (HUMA) United States $0.551B 0.00
Annexon (ANNX) United States $0.551B 0.00
Abivax SA (ABVX) France $0.551B 0.00
GRAIL (GRAL) United States $0.550B 0.00
IGM Biosciences (IGMS) United States $0.529B 0.00
Astria Therapeutics (ATXS) United States $0.527B 0.00
Pharming Group (PHAR) Netherlands $0.526B 0.00
Sana Biotechnology (SANA) United States $0.525B 0.00
PureTech Health (PRTC) United States $0.521B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.521B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.520B 0.00
Third Harmonic Bio (THRD) United States $0.516B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.513B 0.00
Emergent Biosolutions (EBS) United States $0.509B 0.00
GH Research (GHRS) Ireland $0.501B 0.00
Terns Pharmaceuticals (TERN) United States $0.485B 0.00
Celcuity (CELC) United States $0.473B 0.00
MeiraGTx Holdings (MGTX) United States $0.463B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.462B 0.00
REGENXBIO (RGNX) United States $0.455B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.452B 0.00
Aura Biosciences (AURA) United States $0.451B 0.00
Olema Pharmaceuticals (OLMA) United States $0.451B 0.00
Alumis (ALMS) United States $0.446B 0.00
Allogene Therapeutics (ALLO) United States $0.442B 0.00
Zenas BioPharma (ZBIO) United States $0.436B 0.00
ACELYRIN, INC (SLRN) United States $0.434B 0.00
Foghorn Therapeutics (FHTX) United States $0.429B 0.00
Cartesian Therapeutics (RNAC) United States $0.422B 0.00
Sangamo Therapeutics (SGMO) United States $0.409B 0.00
Revance Therapeutics (RVNC) United States $0.403B 0.00
Tango Therapeutics (TNGX) United States $0.390B 0.00
Prime Medicine (PRME) United States $0.390B 0.00
Alpha Teknova (TKNO) United States $0.388B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.379B 0.00
Contineum Therapeutics (CTNM) United States $0.370B 0.00
Northwest Biotherapeutics (NWBO) United States $0.369B 0.00
Alector (ALEC) United States $0.368B 0.00
MaxCyte (MXCT) United States $0.364B 0.00
XOMA Royalty (XOMA) United States $0.354B 0.00
Codexis (CDXS) United States $0.352B 0.00
EnGene Holdings (ENGN) Canada $0.339B 0.00
Kamada (KMDA) Israel $0.336B 20.89
Q32 Bio (QTTB) United States $0.329B 0.00
Jasper Therapeutics (JSPR) United States $0.328B 0.00
AC Immune (ACIU) Switzerland $0.326B 0.00
Design Therapeutics (DSGN) United States $0.315B 0.00
Kodiak Sciences (KOD) United States $0.310B 0.00
Nautilus Biotechnology (NAUT) United States $0.299B 0.00
ITeos Therapeutics (ITOS) United States $0.297B 0.00
Voyager Therapeutics (VYGR) United States $0.297B 7.65
ProQR Therapeutics (PRQR) Netherlands $0.295B 0.00
Absci (ABSI) United States $0.293B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.288B 0.00
UniQure (QURE) Netherlands $0.285B 0.00
C4 Therapeutics (CCCC) United States $0.283B 0.00
Rezolute (RZLT) United States $0.282B 0.00
Semper Paratus Acquisition (TVGN) United States $0.280B 0.00
Eton Pharmaceuticals (ETON) United States $0.278B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Urogen Pharma (URGN) United States $0.271B 0.00
Prima BioMed (IMMP) Australia $0.268B 0.00
Precigen (PGEN) United States $0.264B 0.00
Artiva Biotherapeutics (ARTV) United States $0.264B 0.00
Poseida Therapeutics (PSTX) United States $0.264B 0.00
Ocugen (OCGN) United States $0.262B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Anika Therapeutics (ANIK) United States $0.255B 0.00
Abeona Therapeutics (ABEO) United States $0.252B 0.00
ATyr Pharma (ATYR) United States $0.250B 0.00
Mersana Therapeutics (MRSN) United States $0.245B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.243B 0.00
Benitec Biopharma (BNTC) United States $0.237B 0.00
Fate Therapeutics (FATE) United States $0.236B 0.00
Neurogene (NGNE) United States $0.232B 0.00
Biomea Fusion (BMEA) United States $0.231B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.227B 0.00
BioStem Technologies (BSEM) $0.224B 19.84
Molecular Partners AG (MOLN) Switzerland $0.219B 0.00
Amarin (AMRN) Ireland $0.216B 0.00
GENFIT S.A (GNFT) France $0.212B 0.00
TScan Therapeutics (TCRX) United States $0.210B 0.00
Trevi Therapeutics (TRVI) United States $0.210B 0.00
Solid Biosciences (SLDB) United States $0.209B 0.00
Sutro Biopharma (STRO) United States $0.209B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.207B 0.00
Inhibrx Biosciences (INBX) United States $0.202B 0.00
XBiotech (XBIT) United States $0.202B 0.00
Climb Bio (CLYM) United States $0.202B 0.00
Editas Medicine (EDIT) United States $0.196B 0.00
Zura Bio (ZURA) United States $0.191B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.190B 0.00
Compass Therapeutics (CMPX) United States $0.190B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.188B 0.00
Opthea (OPT) Australia $0.183B 0.00
Caribou Biosciences (CRBU) United States $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.179B 0.00
Actuate Therapeutics (ACTU) United States $0.176B 0.00
Verastem (VSTM) United States $0.175B 0.00
ScPharmaceuticals (SCPH) United States $0.173B 0.00
Inozyme Pharma (INZY) United States $0.173B 0.00
Kyverna Therapeutics (KYTX) United States $0.172B 0.00
Nkarta (NKTX) United States $0.172B 0.00
Tenaya Therapeutics (TNYA) United States $0.171B 0.00
Greenwich LifeSciences (GLSI) United States $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.169B 0.00
2seventy Bio (TSVT) United States $0.163B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.163B 0.00
Instil Bio (TIL) United States $0.162B 0.00
Fulcrum Therapeutics (FULC) United States $0.160B 0.00
Elutia (ELUT) United States $0.152B 0.00
Gossamer Bio (GOSS) United States $0.151B 0.00
Bright Minds Biosciences (DRUG) United States $0.144B 0.00
Puma Biotechnology (PBYI) United States $0.142B 6.04
TuHURA Biosciences (HURA) United States $0.142B 0.00
PepGen (PEPG) United States $0.141B 0.00
Seer (SEER) United States $0.140B 0.00
Inventiva S.A (IVA) France $0.140B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.139B 0.00
Sagimet Biosciences (SGMT) United States $0.138B 0.00
Innate Pharma S.A (IPHA) France $0.138B 0.00
Black Diamond Therapeutics (BDTX) United States $0.138B 0.00
Candel Therapeutics (CADL) United States $0.134B 0.00
Adherex Technologies (FENC) United States $0.129B 0.00
Compugen (CGEN) Israel $0.129B 72.50
Cardiff Oncology (CRDF) United States $0.128B 0.00
Coherus BioSciences (CHRS) United States $0.127B 0.00
Skye Bioscience (SKYE) United States $0.127B 0.00
Repare Therapeutics (RPTX) Canada $0.126B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
Cidara Therapeutics (CDTX) United States $0.123B 0.00
Vigil Neuroscience (VIGL) United States $0.123B 0.00
Ventyx Biosciences (VTYX) United States $0.122B 0.00
Oncobiologics (OTLK) United States $0.121B 0.00
InflaRx (IFRX) Germany $0.121B 0.00
Adverum Biotechnologies (ADVM) United States $0.120B 0.00
Rani Therapeutics Holdings (RANI) United States $0.117B 0.00
TELA Bio (TELA) United States $0.114B 0.00
CAMP4 Therapeutics (CAMP) United States $0.113B 0.00
Alto Neuroscience (ANRO) United States $0.110B 0.00
Inovio Pharmaceuticals (INO) United States $0.106B 0.00
Scilex Holding (SCLX) United States $0.106B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Akoya Biosciences (AKYA) United States $0.105B 0.00
Monopar Therapeutics (MNPR) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.103B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Adagene (ADAG) China $0.100B 0.00
Immunic (IMUX) United States $0.100B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
MediciNova (MNOV) United States $0.098B 0.00
Adlai Nortye (ANL) Cayman Islands $0.096B 0.00
Nuvectis Pharma (NVCT) United States $0.095B 0.00
Annovis Bio (ANVS) United States $0.094B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.092B 0.00
Quince Therapeutics (QNCX) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Generation Bio (GBIO) United States $0.088B 0.00
Genenta Science S.p.A (GNTA) Italy $0.088B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Genelux (GNLX) United States $0.085B 0.00
23andMe Holding (ME) United States $0.084B 0.00
Invivyd (IVVD) United States $0.084B 0.00
FibroBiologics (FBLG) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
Chimerix (CMRX) United States $0.082B 0.00
Allakos (ALLK) United States $0.081B 0.00
Renovaro (RENB) United States $0.079B 0.00
Werewolf Therapeutics (HOWL) United States $0.079B 0.00
I-Mab (IMAB) China $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Oncolytics Biotech (ONCY) Canada $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.075B 0.00
Adicet Bio (ACET) United States $0.075B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.074B 0.00
Aligos Therapeutics (ALGS) United States $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
ALX Oncology Holdings (ALXO) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
CytomX Therapeutics (CTMX) United States $0.068B 5.10
BioAtla (BCAB) United States $0.067B 0.00
Agenus (AGEN) United States $0.067B 0.00
Immuneering (IMRX) United States $0.066B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Spero Therapeutics (SPRO) United States $0.065B 17.00
X4 Pharmaceuticals (XFOR) United States $0.063B 0.00
Celularity (CELU) United States $0.063B 0.00
Atara Biotherapeutics (ATRA) United States $0.061B 0.00
CervoMed (CRVO) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Bluebird Bio (BLUE) United States $0.058B 0.00
Boundless Bio (BOLD) United States $0.057B 0.00
Aadi Bioscience (AADI) United States $0.056B 0.00
Aileron Therapeutics (ALRN) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Kezar Life Sciences (KZR) United States $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Connect Biopharma Holdings (CNTB) United States $0.055B 0.00
Vor Biopharma (VOR) $0.055B 0.00
OnKure Therapeutics (OKUR) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Enzo Biochem (ENZ) United States $0.051B 0.00
BGM Group (BGM) China $0.051B 0.00
Precision BioSciences (DTIL) United States $0.050B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
DBV Technologies S.A (DBVT) France $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Immix Biopharma (IMMX) United States $0.046B 0.00
IO Biotech (IOBT) Denmark $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Fortress Biotech (FBIO) United States $0.043B 0.00
Omega Therapeutics (OMGA) United States $0.043B 0.00
Affimed (AFMD) Germany $0.043B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.040B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.039B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.039B 0.00
Beyond Air (XAIR) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Intensity Therapeutics (INTS) United States $0.037B 0.00
AN2 Therapeutics (ANTX) United States $0.037B 0.00
Rapt Therapeutics (RAPT) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
Elevation Oncology (ELEV) United States $0.036B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Curis (CRIS) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Clene (CLNN) United States $0.034B 0.00
Passage Bio (PASG) United States $0.033B 0.00
Grace Therapeutics (GRCE) Canada $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Lantern Pharma (LTRN) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
KALA BIO (KALA) United States $0.030B 0.00
RenovoRx (RNXT) United States $0.029B 0.00
BRIACELL THERAP (BCTX) Canada $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Longeveron (LGVN) United States $0.028B 0.00
HOOKIPA Pharma (HOOK) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
HCW Biologics (HCWB) United States $0.027B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Equillium (EQ) United States $0.026B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
GeoVax Labs (GOVX) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
BioXcel Therapeutics (BTAI) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Exicure (XCUR) United States $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Spruce Biosciences (SPRB) United States $0.020B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Gelteq (GELS) $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
NKGen Biotech (NKGN) United States $0.012B 0.00
Ensysce Biosciences (ENSC) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Quantum Biopharma (QNTM) Canada $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Onconetix (ONCO) United States $0.009B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Vincerx Pharma (VINC) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Evaxion Biotech (EVAX) Denmark $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Biora Therapeutics (BIOR) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Allarity Therapeutics (ALLR) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Aptose Biosciences (APTO) Canada $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Polyrizon (PLRZ) $0.004B 0.00
Cyclerion Therapeutics (CYCN) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
IN8bio (INAB) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Eterna Therapeutics (ERNA) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00